Biocom California
Let’s Talk About: What’s Hot in Bay Area Biotech
Liberty Ballroom II
South San Francisco, CA 94080
Event summary
Biocom California is an in-depth panel discussion featuring top innovators, entrepreneurs and investors sharing what’s to come from life sciences companies – as related to next-generation therapies. Speakers shared their experiences and recent advancements on cell and gene therapies, with insights from clinical trials to manufacturing and commercialization aspects of the drugs of the future. In this interactive session, attendees connected with key players, learning their latest strategies, challenges and vision for the future.
Featured agenda item
6:00 – 6:45 pm PDT
Panel discussion on forging relationships that will accelerate breakthrough therapies
Cooley partner Lila Hope moderated this panel discussion.
Other panelists included:
- Sam Hawgood, MBBS – Chancellor at the University of California San Francisco
- Michelle L. Hermiston, MD, PhD – Pediatric hematologist-oncologist and professor at the University of California San Francisco
- Dan Herring, Sr. – Director and general manager of cell therapy services at Thermo Fisher Scientific
For more information, please email Kelsey O'Connell.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.